Literature DB >> 28840427

Musculoskeletal system in children and adolescents with inflammatory bowel disease: normal muscle force, decreased trabecular bone mineral density and low prevalence of vertebral fractures.

Klara Maratova1, Ondrej Hradsky1, Jana Matyskova1, Ivana Copova1, Ondrej Soucek2, Zdenek Sumnik1, Jiri Bronsky1.   

Abstract

Low bone mineral density (BMD) and an increased fracture incidence are two extraintestinal complications associated with inflammatory bowel disease (IBD). We aimed to evaluate musculoskeletal traits and assess vertebral fracture (VF) rate in children and adolescents with IBD. Seventy patients with IBD with a median age of 13.8 years were included. The BMD and geometric parameters of the non-dominant tibia were assessed using pQCT. Dynamic muscle functions were evaluated using jumping mechanography. VFs were assessed according to the semiquantitative standardized method by Genant. The muscle functions adjusted for the patients' weight did not differ from the reference population. A low trabecular BMD (Z-score - 1.6; p < 0.001) and cortical thickness (Z-score - 0.7; p < 0.001) were found in children and adolescents with IBD. Conversely, an increased cortical BMD (Z-score 1.1; p < 0.001) was noted. No significant association was found between the 25-OHD serum levels and the bone or muscle measurements. One patient with asymptomatic VF was identified.
CONCLUSION: IBD in childhood or adolescents affects bones but not muscles. Bone changes are independent of the 25-OHD serum level. A thoracolumbar spine X-ray should not be routinely recommended in children with IBD. What is Known: • Low bone mineral density and an increased fracture rate are the complications associated with IBD. • Bone strength and structural development is strongly dependent on skeletal muscle stimulation. What is New: • Children with IBD have altered bone density and geometry but normal dynamic muscle functions. • Thoracolumbar spine X-ray should be indicated on an individual basis in children with IBD.

Entities:  

Keywords:  Bone strength; Inflammatory bowel disease; Mechanography; Muscle functions; Peripheral quantitative computed tomography; Vitamin D

Mesh:

Year:  2017        PMID: 28840427     DOI: 10.1007/s00431-017-2988-7

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  50 in total

1.  Fracture risk is increased in Crohn's disease, but not in ulcerative colitis.

Authors:  P Vestergaard; K Krogh; L Rejnmark; S Laurberg; L Mosekilde
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

2.  Lean body mass, physical activity and quality of life in paediatric patients with inflammatory bowel disease and in healthy controls.

Authors:  Katharina J Werkstetter; Jennifer Ullrich; Stephanie B Schatz; Christine Prell; Berthold Koletzko; Sibylle Koletzko
Journal:  J Crohns Colitis       Date:  2012-01-09       Impact factor: 9.071

3.  The 6th nationwide anthropological survey of children and adolescents in the Czech Republic in 2001.

Authors:  J Kobzová; J Vignerová; P Bláha; L Krejcovský; J Riedlová
Journal:  Cent Eur J Public Health       Date:  2004-09       Impact factor: 1.163

4.  Bone mineral acquisition during adolescence and early adulthood: a study in 574 healthy females 10-24 years of age.

Authors:  J P Sabatier; G Guaydier-Souquières; D Laroche; A Benmalek; L Fournier; F Guillon-Metz; J Delavenne; A Y Denis
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

5.  Bone mineral density and nutritional status in children with chronic inflammatory bowel disease.

Authors:  A M Boot; J Bouquet; E P Krenning; S M de Muinck Keizer-Schrama
Journal:  Gut       Date:  1998-02       Impact factor: 23.059

6.  Improvements in Bone Density and Structure during Anti-TNF-α Therapy in Pediatric Crohn's Disease.

Authors:  Lindsay M Griffin; Meena Thayu; Robert N Baldassano; Mark D DeBoer; Babette S Zemel; Michelle R Denburg; Lee A Denson; Justine Shults; Rita Herskovitz; Jin Long; Mary B Leonard
Journal:  J Clin Endocrinol Metab       Date:  2015-04-28       Impact factor: 5.958

7.  Iliac bone histomorphometry in children with newly diagnosed inflammatory bowel disease.

Authors:  L M Ward; F Rauch; M A Matzinger; E I Benchimol; M Boland; D R Mack
Journal:  Osteoporos Int       Date:  2009-06-06       Impact factor: 4.507

8.  Objectively measured muscle fatigue in Crohn's disease: correlation with self-reported fatigue and associated factors for clinical application.

Authors:  D R van Langenberg; P Della Gatta; S A Warmington; D J Kidgell; P R Gibson; A P Russell
Journal:  J Crohns Colitis       Date:  2013-08-12       Impact factor: 9.071

9.  Osteopenia in Crohn's disease.

Authors:  F J Cowan; D R Parker; H R Jenkins
Journal:  Arch Dis Child       Date:  1995-09       Impact factor: 3.791

10.  Vertebral fractures in patients with inflammatory bowel disease compared with a healthy population: a prospective case-control study.

Authors:  Maria Angeles Vázquez; Enrique Lopez; Maria José Montoya; Mercè Giner; Ramón Pérez-Temprano; Ramón Pérez-Cano
Journal:  BMC Gastroenterol       Date:  2012-05-14       Impact factor: 3.067

View more
  4 in total

Review 1.  The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management.

Authors:  Jane Fletcher; Sheldon C Cooper; Subrata Ghosh; Martin Hewison
Journal:  Nutrients       Date:  2019-05-07       Impact factor: 5.717

2.  Growth, puberty, and bone health in children and adolescents with inflammatory bowel disease.

Authors:  Hye-Young Jin; Jae-Sang Lim; Yena Lee; Yunha Choi; Seak-Hee Oh; Kyung-Mo Kim; Han-Wook Yoo; Jin-Ho Choi
Journal:  BMC Pediatr       Date:  2021-01-14       Impact factor: 2.125

Review 3.  Bone Health in Pediatric Patients with IBD: What Is New?

Authors:  Rebecca J Gordon; Catherine M Gordon
Journal:  Curr Osteoporos Rep       Date:  2021-06-22       Impact factor: 5.096

Review 4.  Metabolic Bone Disorders in Children with Inflammatory Bowel Diseases.

Authors:  Mariusz Olczyk; Elżbieta Czkwianianc; Anna Socha-Banasiak
Journal:  Life (Basel)       Date:  2022-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.